Drug metabolism and pancreatic cancer

Δείτε το αρχείο http://www.annalsgastro.gr/index.php/annalsgastro/article/view/2803  
Φορέας Ελληνική Γαστροεντερολογική Εταιρία
Συλλογή Annals of Gastroenterology Drug metabolism and pancreatic
cancer
Επιμέρους συλλογή Review Articles
ΠεριγραφήPancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.Keywords Chemotherapy, genomic profile, genomics, molecular pancreatic pathogenesis, pancreatic cancer pharmacogenomics, pancreatic exocrine cancer, targeted therapyAnn Gastroenterol 2017; 30 (1): 54-61
Δημιουργοί Saif, Muhammad Wasif Tufts Medical Center Flores, John Paul E.
Συνεργάτης NONE
ΕκδότηςAnnals of Gastroenterology
Ημερομηνία2016-12-29
Μορφότυποςapplication/pdf
Μορφότυποςtext/html
ΠηγήAnnals of Gastroenterology; Volume 30, No 1 (2017); 54
Σχέσηhttp://www.annalsgastro.gr/index.php/annalsgastro/article/do
wnload/2803/15393